| Current Price | $117.95 | Mkt Cap | $12.2B |
|---|---|---|---|
| Open | $119.08 | P/E Ratio | 0.00 |
| Prev. Close | $117.95 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $116.01 - $119.41 | Volume | 65 |
| 52-Wk Range | $108.31 - $232.76 | Avg. Daily Vol. | 405,910 |
| Current Price | $117.95 | Mkt Cap | $12.2B |
|---|---|---|---|
| Open | $119.08 | P/E Ratio | 0.00 |
| Prev. Close | $117.95 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $116.01 - $119.41 | Volume | 65 |
| 52-Wk Range | $108.31 - $232.76 | Avg. Daily Vol. | 405,910 |
The best Bull and Bear pitches based on recency and number of recommendations.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about NVCR.
Recs
san97
(< 20)
Submitted: 9/20/2021 6:36:27 PM :
Start Price:
$128.52
NASDAQ:NVCR Score:
-11.86
It has potential to double
Recs
Rainman19
(36.72)
Submitted: 9/7/2021 7:15:03 AM :
Start Price:
$138.55
NASDAQ:NVCR Score:
-14.80
A unique technology in treating cancer gives NVCR a deep moat. The application of its technology to further types of cancer (not only brain cancer) will move NVCR forward. Strong revenue growth and even positive earnings (adjusted EBITDA of $ 18 million in Q2 2021) also look positive. NVCR is a company that delivers benefits for all of its stakeholders (e.g. 98% approval on glassdoor). The recent drop in the stock price seems to be a perfect entry point to add to one of my winners.
Recs
Desertdavid
(96.81)
Submitted: 8/11/2021 9:49:46 PM :
Start Price:
$143.26
NASDAQ:NVCR Score:
-19.65
Aaron Bush praised it, that's my reasoning for picking it. If he picked peanut butter or horseradish sauce to go up, I'd buy them, too.
Find the members with the highest scoring picks in NVCR.
stcksrus (92.39) Score: +800.68
The Score Leader is the player with the highest score across all their picks in NVCR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
|
stcksrus | 92.39 |
|
|
5Y | $11.69 | +908.98% | +108.30% | +800.68 | 0 Comment |
| synapse | 93.08 | 10/20/2017 |
|
5Y | $18.25 | +546.30% | +76.24% | +470.06 | 0 Comment | |
| findil | 89.50 | 10/23/2017 |
|
5Y | $18.43 | +540.16% | +75.94% | +464.23 | 1 Comment | |
| SuzyP99 | 80.14 | 8/23/2017 |
|
1Y | $18.75 | +529.07% | +85.16% | +443.90 | 1 Comment | |
|
|
skyrocket29 | 69.13 | 8/22/2017 |
|
1Y | $19.10 | +517.54% | +85.74% | +431.80 | 0 Comment |
| kaderoundy | 99.54 |
|
|
NS | $17.98 | +556.01% | +127.40% | +428.61 | 0 Comment | |
| lorenzo404 | 26.75 | 1/15/2016 |
|
3W | $17.58 | +570.93% | +142.35% | +428.58 | 0 Comment | |
| tprooney3 | 96.85 | 7/17/2017 |
|
5Y | $19.25 | +512.73% | +84.30% | +428.42 | 1 Comment | |
| XMFpessen | 86.18 | 12/5/2017 |
|
5Y | $19.95 | +491.38% | +71.20% | +420.18 | 0 Comment | |
| only1ferret | 51.77 | 12/6/2017 |
|
5Y | $20.08 | +487.55% | +71.64% | +415.91 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
